Meropenem
Structural formula | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||||||||||||||
Non-proprietary name | Meropenem | |||||||||||||||||||||
other names |
Latin : Meropenemum |
|||||||||||||||||||||
Molecular formula | C 17 H 25 N 3 O 5 S | |||||||||||||||||||||
Brief description |
white to pale yellow, crystalline powder (meropenem trihydrate) |
|||||||||||||||||||||
External identifiers / databases | ||||||||||||||||||||||
|
||||||||||||||||||||||
Drug information | ||||||||||||||||||||||
ATC code | ||||||||||||||||||||||
Drug class | ||||||||||||||||||||||
Mechanism of action | ||||||||||||||||||||||
properties | ||||||||||||||||||||||
Molar mass | 383.46 g · mol -1 | |||||||||||||||||||||
solubility |
sparingly soluble in water, very sparingly soluble in dilute ethanol , practically insoluble in acetone and diethyl ether (trihydrate) |
|||||||||||||||||||||
safety instructions | ||||||||||||||||||||||
|
||||||||||||||||||||||
Toxicological data | ||||||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Meropenem is a drug that belongs to the group of carbapenems and is sold by AstraZeneca .
pharmacology
See carbapenems , unlike imipenem , meropenem is stable to dehydropeptidase I.
Spectrum of activity
The spectrum of activity is greater in the area of gram-negative bacteria compared to imipenem .
Side effects
The side effects largely correspond to those of penicillins and cephalosporins . However, epileptic seizures can also occur.
Trade names
Meronem (D, CH), Optinem (A)
Web links
- FDA label for Merrem® iv from March 27, 2008 (PDF; 198 kB)
Individual evidence
- ^ A b The Merck Index : An Encyclopedia of Chemicals, Drugs, and Biologicals , 14th Edition (Merck & Co., Inc.), Whitehouse Station, NJ, USA, 2006, p. 1018; ISBN 978-0-911910-00-1 .
- ↑ harmonized classification for this substance . What is shown is a label of (4R, 5S, 6S) -3 - [[(3S, 5S) -5 - [(dimethylamino) carbonyl] -3-pyrrolidinyl] thio] -6 - [(1R ) -1-hydroxyethyl] -4-methyl-7-oxo-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid in the Classification and Labeling Inventory of the European Chemicals Agency (ECHA), accessed on July 8 2020. There is not yet a
- ↑ Entry on meropenem in the ChemIDplus database of the United States National Library of Medicine (NLM), accessed on July 8, 2020.